Nephrology deals with systemic diseases related to various kidney-related conditions, from abnormal urinalysis (proteinuria, hematuria) to renal failure. Nephritis, nephrotic syndrome, diabetic nephropathy, vasculitis, hypertension (nephrosclerosis), collagen disease, acute renal failure, chronic renal failure, and rapidly progressive renal failure associated with drug-related renal failure are treated. In particular, the number of patients in Japan with chronic kidney disease (CKD), which is said to be a major risk factor for cardiovascular complications, is 13.3 million (1 in 8 adults over the age of 20, approximately 200,000 in Kobe City). It is estimated that it is a new national disease. Prevention, early detection, appropriate diagnosis, and early treatment are the most important for kidney disease. For proper diagnosis, about 100 renal biopsies are actively performed annually as needed and reflected in treatment. In addition, we are developing team medical care with registered Registered Dietitian, pharmacists, laboratory technologists, clinical engineers, nurses, etc., holding renal disease classes and promoting renal failure education hospitalization. Furthermore, for patients with renal failure who have advanced renal failure, we introduce blood purification therapy (hemodialysis, peritoneal dialysis) and renal transplantation. In addition to renal disease, we cooperate with other departments to perform plasmapheresis, leukocyte removal therapy, LDL apheresis, and other treatments. In cooperation with university hospitals and Nephrology-related facilities, we develop highly specialized medical and educational activities, and develop close cooperation with nearby medical facilities. In addition, I would like to closely exchange information with my family doctors regarding the diagnosis and treatment of patients, and cooperate with them in providing medical care. In addition, we regularly hold public lectures and research meetings, etc., and strive to provide the latest information on Nephrology care.
Medical record
Departmental statistics
Main diseases/treatments
Disease/examination/treatment
Main disease name. IgA nephropathy, purpura nephritis, post-streptococcal acute glomerulonephritis, minimal change nephrotic syndrome, membranous nephropathy, focal glomerulonephritis, membranous proliferative glomerulonephritis, rapidly progressive glomerulonephritis, such as lupus nephritis.
test
Disease/examination/treatment
Disease/examination/treatment
Chronic kidney disease (CKD) progresses without subjective symptoms, so early detection and early treatment are very important. If proteinuria or hematuria is pointed out during a medical checkup, anemia, nocturia, swelling, changes in urine (increase or decrease in volume, foaming, etc.), or if you continue to feel sluggish, consult a medical institution as soon as possible. will do.
clinical research
With the cooperation of our patients, the Nephrology of our hospital conducts clinical research (observational research, intervention research, clinical trials) aimed at elucidating the cause of disease, improving disease prevention, diagnosis and treatment, and improving the patient's QOL. We are doing.
In the observational study, we use the data from the patient's daily clinical practice, and we do not ask for direct consent, but conduct it as if we have obtained consent with this notice.
In addition, we have received approval from the clinical research ethics committee within the hospital, and we conduct interventional research and clinical trials after obtaining the individual patient's consent.
If you would like a detailed explanation of the research content, object to the clinical research, or have any other questions, please contact us at the contact information below.
Research subject name | Person in charge of our hospital | approval date | Explanatory text (PDF) |
---|---|---|---|
Research on the onset of infection and readmission due to steroid dosage at discharge | Keisuke Osaki | 2024/2/29 | |
Observational study on construction of renal disease database at Kyoto University University Hospital, Department of Nephrology | Akihiro Yoshimoto | 2021/11/18 | |
Investigative research on renin-angiotensin system inhibitors and the relationship between aggravation of COVID-19 infection | Akihiro Yoshimoto | 2020/11/6 |
news
At the blood purification outpatient clinic in the Dialysis and Blood Purification Center on the 4th floor, blood purification therapy (blood adsorption therapy/plasma exchange therapy) is performed for patients with relatively stable general conditions.
Blood purification therapy treats diseases and medical conditions that are difficult to control with conventional oral drugs and injection drugs alone. It's a rejuvenating treatment.
We are also targeting diseases for which no effective treatment has been established so far, and for diseases that were only effective with drugs with strong side effects such as steroids and immunosuppressants. This treatment is aimed at reducing the side effects of In addition, LDL adsorption therapy has been shown to improve the symptoms of arteriosclerosis obliterans (ASO).
Blood purification therapy is a treatment method that is not yet well known as there are limitations to the facilities where it can be performed. We are actively treating.
Many cleansing methods are performed several times on a regular basis to determine effectiveness. Please feel free to contact us regarding insurance coverage and the social security system.
Main diseases treated at our hospital
kidney disease
- Focal glomerulosclerosis (nephrotic syndrome)
cardiovascular disease
- ASO (arteriosclerosis obliterans)
- familial hypercholesterolemia
digestive disorders
- Ulcerative colitis, refractory ascites
autoimmune disease
- rheumatoid arthritis, collagen disease
- nerve and muscle disease
- pemphigus, pemphigoid
Such